Ledger.Open graph →
SEC Form D · filed March 17, 2017

Supreme Pharmaceuticals Inc

Offering
$370K
Sold
$370K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Toronto, Ontario, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

John Fowler · Toronto, Ontario, CanadaExec · DirectorAlan P. Crane · Cambridge, MAExec · DirectorScott Walters · Santa Monica, CADirectorChuck Rifici · SEATTLE, WADirectorNavdeep Dhaliwal · Toronto, Ontario, CanadaExec · DirectorMichael La Brier · Toronto, Ontario, CanadaDirectorGeorge P. Vlasuk · Cambridge, MAExec · DirectorScott Walters · Toronto, Ontario, CanadaDirectorChuck Rifici · SEATTLE, WADirectorNavdeep Dhaliwal · Toronto, Ontario, CanadaExec · DirectorMichael La Brier · Toronto, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗